Pacific Biosciences Of California PACB
NASDAQ PACB
$1.27 +0.00 (+0.00%)
At close: Aug 20, 2026 · 12:23 PM UTC

Pacific Biosciences Of California (PACB) Sales of Property, Plant and Equipment (2015 - 2026)

Pacific Biosciences Of California (PACB) Sales of Property, Plant and Equipment (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Abbott Laboratories 200.11 Bn 194.51 Bn 7.27 Bn -
2 Stryker 129.85 Bn 126.37 Bn 4.50 Bn -
3 Medtronic 119.93 Bn 110.71 Bn 6.41 Bn -
4 Boston Scientific 74.18 Bn 73.64 Bn 3.85 Bn -
5 Edwards Lifesciences 52.54 Bn 48.29 Bn 1.35 Bn -
6 Dexcom 34.76 Bn 32.81 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.25 Bn 32.14 Bn 2.18 Bn -
8 Koninklijke Philips 26.45 Bn 23.13 Bn 4.55 Bn 8.14 Mn
9 Steris 23.29 Bn 22.80 Bn 684.20 Mn -
10 Pacific Biosciences Of California 396.09 Mn 159.21 Mn 12.64 Mn 1.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.90 Mn
Jun 30, 2026 1.90 Mn
Mar 31, 2026 50.00 Mn
Mar 31, 2026 50.00 Mn
Dec 31, 2017 39,000.00
Dec 31, 2017 39,000.00
Sep 30, 2017 -10,000.00
Sep 30, 2017 -10,000.00
Jun 30, 2016 -101,000.00
Jun 30, 2016 -101,000.00
Mar 31, 2016 111,000.00
Mar 31, 2016 111,000.00
Dec 31, 2015 24,000.00
Dec 31, 2015 24,000.00
Sep 30, 2015 6,000.00
Sep 30, 2015 6,000.00